Bank of America
STOK icon

Bank of America’s Stoke Therapeutics STOK Stock Holding History

Bank of America’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.7M Buy
543,095
+336,931
+163% +$11M ﹤0.01% 2501
2025
Q4 		$6.54M Sell
206,164
-43,287
-17% -$1.3M ﹤0.01% 3167
2025
Q3 		$5.86M Sell
249,451
-298,639
-54% -$5.12M ﹤0.01% 3837
2025
Q2 		$6.22M Buy
548,090
+15,206
+3% +$144K ﹤0.01% 3673
2025
Q1 		$3.54M Buy
532,884
+523,793
+5,762% +$4.88M ﹤0.01% 4163
2024
Q4 		$100K Sell
9,091
-115,557
-93% -$1.42M ﹤0.01% 6400
2024
Q3 		$1.53M Buy
124,648
+26,850
+27% +$380K ﹤0.01% 4760
2024
Q2 		$1.32M Buy
97,798
+69,191
+242% +$934K ﹤0.01% 4731
2024
Q1 		$386K Sell
28,607
-46,732
-62% -$283K ﹤0.01% 5499
2023
Q4 		$396K Buy
75,339
+17,781
+31% +$76K ﹤0.01% 5654
2023
Q3 		$227K Buy
57,558
+37,211
+183% +$245K ﹤0.01% 5840
2023
Q2 		$216K Sell
20,347
-5,185
-20% -$55.2K ﹤0.01% 5779
2023
Q1 		$213K Buy
25,532
+520
+2% +$4.69K ﹤0.01% 5897
2022
Q4 		$231K Buy
25,012
+19,161
+327% +$199K ﹤0.01% 5835
2022
Q3 		$75K Sell
5,851
-10,471
-64% -$167K ﹤0.01% 6492
2022
Q2 		$215K Buy
16,322
+7,690
+89% +$117K ﹤0.01% 6036
2022
Q1 		$182K Sell
8,632
-45,110
-84% -$903K ﹤0.01% 6526
2021
Q4 		$1.29M Buy
53,742
+45,345
+540% +$1.08M ﹤0.01% 5000
2021
Q3 		$214K Sell
8,397
-3,926
-32% -$109K ﹤0.01% 6262
2021
Q2 		$415K Sell
12,323
-488
-4% -$17.3K ﹤0.01% 5569
2021
Q1 		$497K Buy
12,811
+9,282
+263% +$528K ﹤0.01% 5371
2020
Q4 		$219K Sell
3,529
-454
-11% -$20.8K ﹤0.01% 5542
2020
Q3 		$134K Sell
3,983
-5,173
-56% -$148K ﹤0.01% 5527
2020
Q2 		$218K Buy
9,156
+3,307
+57% +$78.5K ﹤0.01% 5184
2020
Q1 		$134K Buy
5,849
+2,236
+62% +$55.2K ﹤0.01% 5343
2019
Q4 		$102K Sell
3,613
-101
-3% -$2.54K ﹤0.01% 5988
2019
Q3 		$79K Buy
+3,714
New +$104K ﹤0.01% 6155

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Bank of America's STOK Position: Q1 2026 in Review

Bank of America increased its Stoke Therapeutics (STOK) stake by 163% in Q1 2026, buying an estimated $11M and bringing the position to 543,095 shares worth $17.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2501.

Bank of America first reported a position in STOK in Q3 2019 and has held it in 27 quarters since. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • Bank of America held 543,095 shares of Stoke Therapeutics worth $17.7M as of Q1 2026.
  • Bank of America bought 336,931 Stoke Therapeutics shares in Q1 2026, an estimated $11M.
  • Stoke Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2501 holding.
  • Bank of America first reported a position in Stoke Therapeutics in Q3 2019 and has held it in 27 quarters since.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.